Inozyme Pharma, Inc. 3 SEC Filings

Filed On	Filing
07 Oct 2024	Form 3: Harris Erik, Director No securities owned
04 Apr 2023	Form 3: Winton Matthew, COO No securities owned
22 Mar 2022	Form 3: Subramanian Sanjay, SVP, CFO No securities owned
18 May 2021	Form 3: DiPalma Stephen J., Interim CFO No securities owned
04 Feb 2021	Form 3: Wenkert Deborah, SVP, CMO No securities owned
23 Jul 2020	Form 3: Alexion PHARMACEUTICALS, Inc., 10% owner
23 Jul 2020	Form 3: Hopfner Robert Lorne, Director
23 Jul 2020	Form 3: Jungles Steven J, See Remarks Holds 42,036 shares of Common Stock
23 Jul 2020	Form 3: Basso Stephen, Senior Vice President, Finance
23 Jul 2020	Form 3: Rock Springs Capital Management Lp, 10% owner and 2 others
23 Jul 2020	Form 3: Sofinnova Venture Partners X, L.p., 10% owner and 4 others
23 Jul 2020	Form 3: Edwards Martin, Director No securities owned
23 Jul 2020	Form 3: Bhagat Sarah M, Director No securities owned
23 Jul 2020	Form 3: Diaz Reinaldo M, Director No securities owned
23 Jul 2020	Form 3: Huertas Pedro, See Remarks
23 Jul 2020	Form 3: Longitude Capital Partners III, Llc, 10% owner and 3 others
23 Jul 2020	Form 3: Schlessinger Joseph, 10% owner Holds 273,098 shares of Common Stock
23 Jul 2020	Form 3: Sonsini Peter W., 10% owner
23 Jul 2020	Form 3: Bjarke Henric Bjorn, See Remarks Holds 53,526 shares of Common Stock
23 Jul 2020	Form 3: Sandell Scott D, 10% owner

Comments